REQUEST A DEMO
Total
USD $0.00
Search more companies

A. Menarini Asia-Pacific Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: A. Menarini Asia-Pacific Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: wholesale of medicinal and pharmaceutical products (western) (wholesale of medicinal & pharmaceutical products, cosmetics & medical devices); Secondary Business Activity: wholesale of health supplements (wholesale of health supplements including nutrients & foods)

Headquarters
30 Pasir Panjang Road, #08-32 Mapletree Business City, Singapore
Singapore; Singapore; Postal Code: 117440

Contact Details: Purchase the A. Menarini Asia-Pacific Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the A. Menarini Asia-Pacific Pte. Ltd. report to view the information.
Outstanding Shares:
Purchase the A. Menarini Asia-Pacific Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the A. Menarini Asia-Pacific Pte. Ltd. report to view the information.
Incorporation Date:
January 19, 2005
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
A. Menarini (Thailand) Limited (Thailand)
A. Menarini Hong Kong Limited (Hong Kong SAR, China)
Company Performance
Financial values in the chart are available after A. Menarini Asia-Pacific Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
27.91%
Total operating revenue
27.91%
Net Profit (Loss) for the Period
53.33%
Total assets
6.04%
Total equity
2.33%
Net Profit Margin
0.51%
Return on Equity (ROE)
0.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?